BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8980909)

  • 1. Urinary trypsin inhibitor efficiently inhibits urokinase production in tumor necrosis factor-stimulated cells.
    Kobayashi H; Gotoh J; Terao T
    Eur J Cell Biol; 1996 Dec; 71(4):380-6. PubMed ID: 8980909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary trypsin inhibitor, a Kunitz-type protease inhibitor, modulates tumor necrosis factor-stimulated activation and translocation of protein kinase C in U937 cells.
    Kobayashi H; Sugino D; Terao T
    Int J Oncol; 1998 Jan; 12(1):95-105. PubMed ID: 9454892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of protein kinase C in tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator.
    Niedbala MJ; Stein-Picarella M
    Blood; 1993 May; 81(10):2608-17. PubMed ID: 7683925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C- and MEK/ERK/c-Jun-dependent signaling pathways.
    Kobayashi H; Suzuki M; Tanaka Y; Hirashima Y; Terao T
    J Biol Chem; 2001 Jan; 276(3):2015-22. PubMed ID: 11050091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
    Langer DJ; Kuo A; Kariko K; Ahuja M; Klugherz BD; Ivanics KM; Hoxie JA; Williams WV; Liang BT; Cines DB
    Circ Res; 1993 Feb; 72(2):330-40. PubMed ID: 7678205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of a conjugate between human urokinase and urinary trypsin inhibitor on tumor cell invasion in vitro.
    Kobayashi H; Gotoh J; Hirashima Y; Fujie M; Sugino D; Terao T
    J Biol Chem; 1995 Apr; 270(14):8361-6. PubMed ID: 7713945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of urokinase-type plasminogen activator expression from human ovarian cancer cells by urinary trypsin inhibitor.
    Kobayashi H; Suzuki M; Sun GW; Hirashima Y; Terao T
    Biochim Biophys Acta; 2000 Sep; 1481(2):310-6. PubMed ID: 11018722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C synergistically stimulates tumor necrosis factor-alpha-induced secretion of urokinase-type plasminogen activator in human dental pulp cells.
    Hashizume H; Kamio N; Nakao S; Matsushima K; Sugiya H
    J Physiol Sci; 2008 Feb; 58(1):83-6. PubMed ID: 18177545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator mediated proteolysis of extracellular matrix and its antagonism by gamma-interferon.
    Niedbala MJ; Picarella MS
    Blood; 1992 Feb; 79(3):678-87. PubMed ID: 1732009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor induction of urokinase-type plasminogen activator in human endothelial cells.
    Niedbala MJ; Stein M
    Biomed Biochim Acta; 1991; 50(4-6):427-36. PubMed ID: 1801706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bifunctional hybrid molecule of the amino-terminal fragment of urokinase and domain II of bikunin efficiently inhibits tumor cell invasion and metastasis.
    Kobayashi H; Sugino D; She MY; Ohi H; Hirashima Y; Shinohara H; Fujie M; Shibata K; Terao T
    Eur J Biochem; 1998 May; 253(3):817-26. PubMed ID: 9654084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha inhibition of 17 alpha-hydroxylase/C17-20 lyase gene (Cyp17) expression.
    Li X; Youngblood GL; Payne AH; Hales DB
    Endocrinology; 1995 Aug; 136(8):3519-26. PubMed ID: 7628389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase expression in mononuclear phagocytes: cytokine-specific modulation by interferon-gamma and tumor necrosis factor-alpha.
    Gyetko MR; Shollenberger SB; Sitrin RG
    J Leukoc Biol; 1992 Mar; 51(3):256-63. PubMed ID: 1311745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of intercellular adhesion molecule-1 by tumor necrosis factor-alpha through the 55-kDa receptor is dependent on protein kinase C in human retinal pigment epithelial cells.
    Sippy BD; Hofman FM; Wright AD; Wang JL; Gopalakrishna R; Gundimeda U; He S; Ryan SJ; Hinton DR
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):597-606. PubMed ID: 8595959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overproduction of urokinase-type plasminogen activator is regulated by phospholipase D- and protein kinase C-dependent pathways in murine mammary adenocarcinoma cells.
    Aguirre Ghiso JA; Alonso DF; Farías EF; Bal de Kier Joffé E
    Biochim Biophys Acta; 1997 Apr; 1356(2):171-84. PubMed ID: 9150275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C down-regulation enhances cAMP-mediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells.
    Ziegler A; Knesel J; Fabbro D; Nagamine Y
    J Biol Chem; 1991 Nov; 266(31):21067-74. PubMed ID: 1718970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of cell-surface-associated plasminogen activation in cultured keratinocytes by interleukin-1 beta and tumor necrosis factor-alpha.
    Bechtel MJ; Reinartz J; Rox JM; Inndorf S; Schaefer BM; Kramer MD
    Exp Cell Res; 1996 Mar; 223(2):395-404. PubMed ID: 8601416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
    Gross TJ; Sitrin RG
    J Immunol; 1990 Mar; 144(5):1873-9. PubMed ID: 2307845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A soybean Kunitz trypsin inhibitor suppresses ovarian cancer cell invasion by blocking urokinase upregulation.
    Kobayashi H; Suzuki M; Kanayama N; Terao T
    Clin Exp Metastasis; 2004; 21(2):159-66. PubMed ID: 15168733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.